---

Aromatase Inhibitors: A Safer Approach for the Treatment of Breast Cancer

Full Text PDF

---

Review Article

Author Details : Chiragkumar J. Gohil, Malleshappa N. Noolvi

Volume : 2, Issue : 4, Year : 2015

Article Page : 192-198

Suggest article by email

Get Permission

Abstract

Breast cancer is the second leading cause of cancer death in women. About two-thirds of breast cancers are termed hormone-dependent breast cancer, which contains estrogen receptors (ER) and requires estrogen for tumor growth. Aromatase, the enzyme involved in the last step of the biosynthesis of estrogens from androgens, are potential targets for the prevention and treatment of this type of breast cancer. Aromatase inhibitors can markedly suppress plasma estrogen levels by inhibiting aromatase. However, these compounds inhibit aromatase activity in a global fashion and thus could adversely impact sites where estrogen is required for normal function. This drawback has encouraged researchers to develop new drugs that can selectively inhibit aromatase for breast cancer.

 

How to cite : Gohil C J, Noolvi M N, Aromatase Inhibitors: A Safer Approach for the Treatment of Breast Cancer. Int J Pharm Chem Anal 2015;2(4):192-198

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.